The company deploys "safe production month" series of activities
Release time:
2020-08-14
Company Deploys "Safety Production Month" Series Activities
News National "Safety Production Month" is coming soon. Recently, the Safety Committee of the Group Company issued a notice to deploy the company's "Safety Production Month" series activities in combination with the company's activities of creating accident-free factories and the characteristics of 2018 "Safety Education Year.
The guiding ideology of this "Safety Production Month" activity is to create a strong safety production atmosphere and make the safety culture deeply rooted in the hearts of the people, so that more employees can participate in the safety management work and create a safe and stable Work environment, build a safe factory and a happy factory. The notice requires all subordinate units to make their own specific implementation plans according to the company's overall plan, and carefully organize and implement them around the theme of "life first, safe development.
series of activities mainly include publicity and education, safety knowledge competition, safety hazard investigation, emergency drills, etc. In terms of publicity and education, all units are required to carry out publicity in various forms, such as blackboard newspaper, posting posters, organizing safety training, holding knowledge competitions, watching safety education films, safety picture exhibitions, and holding speech competitions, according to the education and training plan of the "year of safety education", and actively organize the study of the "safety production law" and the "safety education reader" of the group company. During the "safe production month", the group company will organize each unit to carry out a mutual safety inspection, and require each unit to be led by the main person in charge to carry out an internal safety production inspection, mobilize employees to carry out the activity of "each person to check a hidden danger and put forward a safety management proposal", and timely rectify the hidden dangers found. According to the situation that there were many accidents in special operations in the past, the safety committee suggested that all units should carry out emergency rescue drills for the weak links in special operations, and further analyze the causes of accidents after the drills, so as to carry out the study of special operation management system.
As an important part of the safety production month, the safety production knowledge competition is scheduled to be held on 6 September 26 . At that time, there will be eight teams from Daye Peak, Yunnan Peak, Peak Pharmaceutical Production Enterprise, Peak Pharmaceutical Management Enterprise, Peak Health, International Trade, Peak Cable and Group Headquarters, with three people in each team. The ranking will be determined in the form of written written examination preliminaries and on-site question-and-answer semi-finals. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page